Author: Iana Dreyer

Enforcement - agenda, regulation European Parliament Intellectual property Latest news Steel

INTA committee: pharma IP, enforcement regulation, steel, chief enforcement officer

Today the international trade committee met for a somewhat longer session than the one held at the end of April at the height of Europe’s lockdown. Here some highlights of what’s been said. Pharma intellectual property The pharmaceutical intellectual property space is one to watch very closely post COVID-19. It …

Coronavirus response Latest news

Pharma, raw materials, taxes, strategic autonomy – the trade dimension of the Commission’s recovery plans

The European Commission’s post-COVID-19 ‘recovery plan’ released today amidst strong media attention focuses mainly on financial and budget issues. But the governance of trade and global value chains is also a significant dimension of how Brussels sees a way out of the pandemic-induced slump. The European Commission adjusted its 2020 …

A week in Brussels Latest news SSAfrica Turkey & Med

Week in Brussels: Turkey pharma case, Africa, Biodiversity

Turkey pharma case in WTO The European Commission published this week its first legal submission in a dispute it filed against Turkey last year at the World Trade Organization concerning the EU’s neighbour’s restrictive policies in the area of pharmaceuticals. The case ‘Certain Measures concerning the Production, Importation and Marketing …

Coronavirus response European Parliament Latest news

Lange: check IP rules in EU FTAs to fight COVID-19 pandemic

The chair of the European Parliament’s international trade committee is asking the European Union to look into some intellectual property rules in its trade policies and agreements with the view of making any future COVID-19 vaccine accessible to the largest numbers in the shortest possible period of time. In a …